Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy
Status:
RECRUITING
Trial end date:
2026-07-04
Target enrollment:
Participant gender:
Summary
The aim of the current study is to measure the effect of melatonin as adjunct therapy on oxidative stress, inflammatory markers and clinical outcome in type 2 diabetic patients with diabetic peripheral neuropathy.